 CAMBRIDGE, Mass., Feb. 28, 2022 GLOBE NEWSWIRE -- Agios Pharmaceuticals, Inc. NASDAQ: AGIO, a leader in the field of cellular metabolism pioneering therapies for genetically defined diseases, today announced the company is scheduled to present at the following March investor conferences: 